Tvardi Therapeutics, Inc. (TVRD)
(Delayed Data from NSDQ)
$23.93 USD
+0.81 (3.48%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $23.46 -0.47 (-1.94%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Tvardi Therapeutics, Inc. has a market cap of $216.42M, which represents its share price of $23.12 multiplied by its outstanding shares number of 9.36M. As a small-cap company, TVRD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TVRD 23.93 +0.81(3.48%)
Will TVRD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TVRD based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TVRD
Tvardi Therapeutics management to meet with Piper Sandler
Tvardi Therapeutics management to meet with Piper Sandler
Upcoming Meetings for TVRD Scheduled in Boston and New York | TVRD Stock News
Tvardi Therapeutics management to meet with Piper Sandler
Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference | TVRD Stock News